News for Healthier Living

Clinical Trial Shows Newborns with Spinal Muscular Atrophy (SMA) Can Start Treatment at Birth

Results from an international clinical trial found that risdiplam, a drug used to treat the rare neurodegenerative disorder Spinal Muscular Atrophy (SMA), is safe and effective in newborns.

August 13, 2025


August 14 2025

August 13 2025

August 12 2025

August 11 2025

August 10 2025

August 9 2025

August 8 2025

August 7 2025

August 6 2025

August 5 2025

August 4 2025

August 3 2025

August 2 2025

August 1 2025